|
|
|
| home > news > detailed info |
|
|
 INDUSTRY NEWS AND PRESS RELEASES |
High performance range of insulated shipping systems |
 |
|
Laminar Medica’s Chilltherm® Global range of high performance insulated shipping systems, from 4 to 1130 litres product volume, are designed to offer optimal thermal protection for pharmaceutical products when exposed to extreme climates from -20°C to +40°C.
These shipping systems are pre-qualified to maintain payload integrity between +2°C and +8°C for transit durations of up to 120 hours. Real live data profiles have been used to give customers confidence that the quality and efficacy of their payloads will not be compromised during even the most demanding external temperatures. Cross hemisphere profile testing makes it ideal for clients making transcontinental shipments.
With only three sizes of cool packs used across the range and a common bill of materials for summer and winter pack outs the impact to warehousing and handling is minimised. |
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Intelsius Introduces Revised PharmaTherm™ Solutions
YORK, England – Intelsius, a DGP company, a designer,
manufacturer and distributor of temperature-controlled packaging
solutions, introduced revisions to its PharmaTherm™ line of solutions to
pharmaceutical industry professionals today at the 13th Annual Cool
Chain Europe Summit in Luxembourg.
More info >> |
|
 |
White Papers |
 |
|
Competitive Drive: The Challenges of a Globalised Packaging Industry
Aesica Pharmaceuticals
Packaging is becoming an increasingly competitive and lucrative industry globally. Jeremy Drummond PhD of Aesica Formulated Products looks at the challenges and opportunities this presents.
More info >> |
|
 |
Industry Events |
 |
10th Pediatric Clinical Trials
11-12 June 2014, Philadelphia, PA, USA
The10th Pediatric Clinical
Trials Conference will provide executives with successful tools and best
practices to effectively submit a PIP that meets FDA and EMA regulations, leverage clinical pharmacology data into
data used in a pediatric clinical trial design, utilize unique recruitment
tactics to improve participation and retention in clinical trials, and expedite
drug development for the pediatric population.
More info >> |
|
|
